Progression-free survival and relapse rate in CLL patients treated with 2-CdA + P vs Chl + P as a first-line treatment
| Characteristics . | No. patients relapsed (%) . | PFS median (mo) . | Died (%) . | |
|---|---|---|---|---|
| ≤12 mo . | >12 mo . | |||
| 2-CdA + P | 17/109 (16) | 30/109 (27) | 21 | 25 (20) |
| Chl + P | 22/58 (38) | 12/58 (21) | 18 | 17 (17) |
| Characteristics . | No. patients relapsed (%) . | PFS median (mo) . | Died (%) . | |
|---|---|---|---|---|
| ≤12 mo . | >12 mo . | |||
| 2-CdA + P | 17/109 (16) | 30/109 (27) | 21 | 25 (20) |
| Chl + P | 22/58 (38) | 12/58 (21) | 18 | 17 (17) |